SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-067259
Filing Date
2005-03-31
Accepted
2005-03-31 17:14:41
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 963006
2 CERTIFICATIONS OF CEO AND CFO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9178
3 CERTIFICATION PURSUANT TO RULE 15D-14 TO SECTION 302 dex312.htm EX-31.2 7875
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3643
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 TO SECTION 906 dex322.htm EX-32.2 3948
  Complete submission text file 0001193125-05-067259.txt   989774
Mailing Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063
Business Address 1300 SEAPORT BOULEVARD REDWOOD CITY CA 94063 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51136 | Film No.: 05721712
SIC: 2834 Pharmaceutical Preparations